Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v10-EN
Language French English
Date Updated 2023-09-06 2023-08-21
Drug Identification Number 02302438 02302438
Brand name XYLOCAINE 2% XYLOCAINE 2%
Common or Proper name lidocaine HCI 2% Plain 10x50mL MD Vial lidocaine HCI 2% Plain 10x50mL MD Vial
Company Name ASPEN PHARMACARE CANADA INC. ASPEN PHARMACARE CANADA INC.
Ingredients LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE
Strength(s) 20MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration BLOCK/INFILTRATION BLOCK/INFILTRATION BLOCK/INFILTRATION BLOCK/INFILTRATION
Packaging size 10 vials 10 vials
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2023-08-20 2023-08-20
Actual start date
Estimated end date 2023-08-20 2023-08-20
Actual end date 2023-08-17
Shortage status Avoided shortage Actual shortage
Tier 3 Status No No
Company comments VR44565CA1 XYLOCAINE 20MG/ML LIQ MDV 10X50ML CA ASP VR44565CA1 XYLOCAINE 20MG/ML LIQ MDV 10X50ML CA ASP
Health Canada comments